BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.26.0//EN
X-ORIGINAL-URL:https://steven-kantor.com/
X-WR-CALNAME:Steven A Kantor
X-WR-CALDESC:
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T010000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-23685a2431acad7789c1e3d43ea1522c@steven-kantor.com
DTSTART;TZID=America/New_York:20260428T080000
DTEND;TZID=America/New_York:20260428T180000
DTSTAMP:20260428T080010Z
CREATED:20260428
LAST-MODIFIED:20260501
PRIORITY:5
SEQUENCE:7
TRANSP:OPAQUE
SUMMARY:Life Sciences Collaborative – Boston Meeting Highlights QSM Diagnostics and Growth in Animal Health
DESCRIPTION:The Life Sciences Collaborative – Boston Chapter (LSC Boston) held its April 2026 meeting at Cushman & Wakefield (125 High Street, Boston), bringing together life sciences executives, angel investors, and venture capital professionals for a focused discussion on innovation in diagnostics and emerging market opportunities.\nThe session featured Edgar D. Goluch, PhD, Founder & CEO of QSM Diagnostics, Inc., who provided an overview of the company’s technology and strategic direction.\nAdvancing Diagnostics in the Animal Health Market\nDr. Goluch presented QSM Diagnostics’ platform, which is currently being applied in the animal health space, particularly in pet diagnostics. The technology is designed to improve the speed and accuracy of detecting infections, addressing a growing need for more efficient diagnostic solutions in veterinary care.\nThe animal health sector continues to expand rapidly, creating opportunities for companies that can deliver innovative, scalable solutions.\nGrowth Strategy and Capital Raise\nQSM Diagnostics is currently in the process of raising capital, and Dr. Goluch shared insight into how the company plans to deploy funds to accelerate growth. The strategy includes expanding within the animal health market while continuing to refine and scale the technology.\nThe discussion also addressed the company’s long-term vision, including the potential to pursue regulatory approvals for entry into the human diagnostics market.\nConnecting Operators and Investors\nThe meeting brought together a diverse group of participants, including life sciences industry executives, angel investors, and venture capital professionals. The exchange of perspectives between operators and investors provided valuable insight into both the opportunities and challenges of building and funding life sciences companies.\nEvents like this reinforce the value of the Life Sciences Collaborative as a forum for sharing real-world experience, fostering relationships, and supporting innovation across the Boston life sciences ecosystem.\n
URL:https://steven-kantor.com/events/life-sciences-collaborative-boston-meeting-highlights-qsm-diagnostics-and-growth-in-animal-health/
CATEGORIES:Life Sciences Collaborative,LSC - Boston
ATTACH;FMTTYPE=image/jpeg:https://steven-kantor.com/wp-content/uploads/2026/04/IMG_9112-3-rotated-e1777482781885.jpeg
END:VEVENT
END:VCALENDAR